Skip to content

Addition of Probenecid to Penicillin-V Therapy

Addition of Probenecid to Penicillin-V Therapy: an Open Label, Cross-over Study in Healthy Volunteers

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05082909
Acronym
ADDPROPEN
Enrollment
21
Registered
2021-10-19
Start date
2021-12-21
Completion date
2022-07-07
Last updated
2025-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection, Bacterial

Keywords

Penicillin, Probenecid, Pharmacokinetics

Brief summary

This study aims to build on previous work characterising the PK of penicillin-V to explore the potential impact of probenecid on PK-PD target attainment. Achievement of the aims of this study would provide data to support the design of experimental studies exploring the clinical impact of probenecid on treatment outcomes and also provide a rationale for exploration of probenecid's effects on a larger number of beta-lactam antibiotics. Hypothesis: Addition of probenecid to oral phenoxymethylpenicillin (penicillin-V) has a clinically relevant effect on pharmacokinetic-pharmacodynamic (PK-PD) target attainment.

Detailed description

Participants will be screened and consented to attend Imperial College Clinical Research Facility (CRF) at Hammersmith Hospital on two study visits, at least 7 days apart. For one visit (randomised), participants will be required to take penicillin-V only. For their other visit, they will take penicillin-V plus probenecid at standard recommended dose. Prior to the study visits, participants may be required to have taken 36-hours of penicillin +/- probenecid, documenting this in a dosing diary. On arrival at the CRF, the participant will take an observed dose of penicillin +/- probenecid. They will undergo blood draw via needle phlebotomy or a cannula (participant choice) at 45 and 180 minutes post the observed. Samples will be spun down and frozen at -80oC. They will subsequently be analysed using an in-house HPLC-MS/MS methodology to determine total and free-unbound drug concentration. For analysis, data from this study will be pooled with rich PK data from a prior study that assessed plasma concertation of penicillin-V in healthy volunteers. Pmetrics in R will be used to model the data looking to explore the effect of probenecid on clearance of free-penicillin-V. Probability of target attainment for streptococci species will also be estimated to evaluate the potential clinical impact of the addition of probenecid to routine penicillin-V use. Rich PK data for intravenous benzylpenicillin will be used to estimate PK-PD target attainment and PTAs for intravenous formulations, allowing direct comparison of oral and IV regimes.

Interventions

DRUGProbenecid

Addition of 500mg QDS to oral penicillin.

Sponsors

Imperial College London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomised, cross-over study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult healthy volunteers (\>18 years old). * Previously taken penicillin-based antibiotics without allergic response. * Estimated Glomerular Filtration Rate (eGFR) \> 90.

Exclusion criteria

* Lacking capacity to consent. * Documented allergy to penicillin, other beta-lactam antibiotics, or probenecid. * History of G6PD Deficiency. * Known blood dyscrasias. * Anaemia (Hb \< 12g/dL female, 13g/dL males). * Abnormal liver function (ALT, AST, ALP or bilirubin \> ULN). * eGFR \< 90. * Pregnant or likely to become pregnant during study period. * Breastfeeding women. * Symptoms consistent with active infection. * History of gout or uric acid kidney stones. * Taking regular medication that may interact with probenecid including, but not limited to methotrexate, lorazepam, acetaminophen, oral hypoglycaemic medication, sulfa containing drugs, non-steroidal anti-inflammatory drugs. * History of evidence of any medical, neurological, or psychological condition that would expose the subject to an undue risk of a significant adverse event or interfere with study assessments during the course of the trial as determined by the clinical judgement of the investigator. * Recent involvement in other research (within prior 3 months).

Design outcomes

Primary

MeasureTime frameDescription
Measurement of Total and Unbound Penicillin-V Concentration45 minutes post an observed dose.Measurement of blood concentration at 45 minutes post dose with and without probenecid.

Secondary

MeasureTime frameDescription
Measurement of Total and Unbound Probenecid Concentration45 minutes post an observed dose.Measurement of blood concentration at 45 minutes post observed probenecid dose. Combined data for all participants given that the same dose of probenecid was taken by all participants.

Countries

United Kingdom

Participant flow

Participants by arm

ArmCount
Penicillin 250mg QDS THEN Penicillin 250mg QDS Plus Probenecid 500mg QDS
Sequence: 1. Penicillin orally at dose of 250mg QDS for 36 hours. 2. Washout period 3. Penicillin orally at dose of 250mg QDS and probenecid 500mg QDS to oral penicillin for 36 hours.
3
Penicillin 500mg QDS THEN Penicillin 500mg QDS Plus Probenecid 500mg QDS
Sequence: 1. Penicillin orally at dose of 500mg QDS for 36 hours. 2. Washout period 3. Penicillin orally at dose of 500mg QDS and probenecid 500mg QDS to oral penicillin for 36 hours.
4
Penicillin 750mg QDS THEN Penicillin 750mg QDS Plus Probenecid 500mg QDS
Sequence: 1. Penicillin orally at dose of 750mg QDS for 36 hours. 2. Washout period 3. Penicillin orally at dose of 750mg QDS and probenecid 500mg QDS to oral penicillin for 36 hours
4
Penicillin 250mg QDS Plus Probenecid 500mg QDS THEN Penicillin 250mg QDS
Sequence: 1. Penicillin orally at dose of 250mg QDS and probenecid 500mg QDS to oral penicillin for 36 hours 2. Washout period 3. Penicillin orally at dose of 250mg QDS for 36 hours.
2
Penicillin 500mg QDS Plus Probenecid 500mg QDS THEN Penicillin 500mg QDS
Sequence: 1. Penicillin orally at dose of 500mg QDS and probenecid 500mg QDS to oral penicillin for 36 hours 2. Washout period 3. Penicillin orally at dose of 500mg QDS for 36 hours.
6
Penicillin 750mg QDS Plus Probenecid 500mg QDS THEN Penicillin 750mg QDS
Sequence: 1. Penicillin orally at dose of 750mg QDS and probenecid 500mg QDS to oral penicillin for 36 hours 2. Washout period 3. Penicillin orally at dose of 750mg QDS for 36 hours.
2
Total21

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003FG004FG005
Overall StudyProtocol Violation001000

Baseline characteristics

CharacteristicPenicillin 500mg QDS THEN Penicillin 500mg QDS Plus Probenecid 500mg QDSPenicillin 250mg QDS THEN Penicillin 250mg QDS Plus Probenecid 500mg QDSTotalPenicillin 750mg QDS Plus Probenecid 500mg QDS THEN Penicillin 750mg QDSPenicillin 500mg QDS Plus Probenecid 500mg QDS THEN Penicillin 500mg QDSPenicillin 250mg QDS Plus Probenecid 500mg QDS THEN Penicillin 250mg QDSPenicillin 750mg QDS THEN Penicillin 750mg QDS Plus Probenecid 500mg QDS
Age, Continuous55 years
STANDARD_DEVIATION 11
50 years
STANDARD_DEVIATION 18
53 years
STANDARD_DEVIATION 17
30 years
STANDARD_DEVIATION 2
67 years
STANDARD_DEVIATION 6
48 years
STANDARD_DEVIATION 22
52 years
STANDARD_DEVIATION 14
Albumin41 g/L
STANDARD_DEVIATION 2
42 g/L
STANDARD_DEVIATION 3
41 g/L
STANDARD_DEVIATION 2
43 g/L
STANDARD_DEVIATION 1
40 g/L
STANDARD_DEVIATION 2
41 g/L
STANDARD_DEVIATION 3
41 g/L
STANDARD_DEVIATION 2
Creatinine68 micromol/L
STANDARD_DEVIATION 6
62 micromol/L
STANDARD_DEVIATION 5
68 micromol/L
STANDARD_DEVIATION 9
78 micromol/L
STANDARD_DEVIATION 5
70 micromol/L
STANDARD_DEVIATION 7
64 micromol/L
STANDARD_DEVIATION 3
69 micromol/L
STANDARD_DEVIATION 2
Height169 cm
STANDARD_DEVIATION 10
167 cm
STANDARD_DEVIATION 10
171.5 cm
STANDARD_DEVIATION 7.8
179 cm
STANDARD_DEVIATION 3
174 cm
STANDARD_DEVIATION 4
171 cm
STANDARD_DEVIATION 5
170 cm
STANDARD_DEVIATION 5
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United Kingdom
4 participants3 participants21 participants2 participants6 participants2 participants4 participants
Sex: Female, Male
Female
1 Participants1 Participants8 Participants0 Participants4 Participants1 Participants1 Participants
Sex: Female, Male
Male
3 Participants2 Participants13 Participants2 Participants2 Participants1 Participants3 Participants
Weight68 Kilograms
STANDARD_DEVIATION 8
68 Kilograms
STANDARD_DEVIATION 5
72 Kilograms
STANDARD_DEVIATION 9
88 Kilograms
STANDARD_DEVIATION 1
71 Kilograms
STANDARD_DEVIATION 6
70 Kilograms
STANDARD_DEVIATION 0
74 Kilograms
STANDARD_DEVIATION 11

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 200 / 20
other
Total, other adverse events
7 / 208 / 20
serious
Total, serious adverse events
0 / 200 / 20

Outcome results

Primary

Measurement of Total and Unbound Penicillin-V Concentration

Measurement of blood concentration at 45 minutes post dose with and without probenecid.

Time frame: 45 minutes post an observed dose.

ArmMeasureGroupValue (MEAN)Dispersion
250mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin alone2.07 mg/LStandard Deviation 0.16
250mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin alone0.39 mg/LStandard Deviation 0.04
250mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin plus probenecid4.83 mg/LStandard Deviation 0.91
250mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin plus probenecid1.58 mg/LStandard Deviation 0.87
250mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin plus probenecid7.45 mg/LStandard Deviation 1.05
250mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin alone0.56 mg/LStandard Deviation 0.01
250mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin alone2.8 mg/LStandard Deviation 0.1
250mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin plus probenecid1.74 mg/LStandard Deviation 0.14
500mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin plus probenecid2.36 mg/LStandard Deviation 0.59
500mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin plus probenecid10.88 mg/LStandard Deviation 2.41
500mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin alone0.97 mg/LStandard Deviation 0.22
500mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin alone5.03 mg/LStandard Deviation 1.46
500mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin alone3.62 mg/LStandard Deviation 1.56
500mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin plus probenecid1.52 mg/LStandard Deviation 0.76
500mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin alone0.65 mg/LStandard Deviation 0.27
500mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin plus probenecid6.50 mg/LStandard Deviation 3.2
750mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin plus probenecid12 mg/LStandard Deviation 2.27
750mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin plus probenecid2.63 mg/LStandard Deviation 0.64
750mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin alone1.22 mg/LStandard Deviation 0.34
750mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin alone6.53 mg/LStandard Deviation 5.38
750mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin alone1.08 mg/LStandard Deviation 0.15
750mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin plus probenecid12 mg/LStandard Deviation 3
750mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin plus probenecid2.84 mg/LStandard Deviation 0.77
750mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin alone6.2 mg/LStandard Deviation 0.8
Primary

Measurement of Total and Unbound Penicillin-V Concentration

Measurement of blood concentration at 180 minutes post dose with and without probenecid.

Time frame: 180 minutes post an observed dose.

ArmMeasureGroupValue (MEAN)Dispersion
250mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin alone0.13 mg/LStandard Deviation 0.05
250mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin alone0.03 mg/LStandard Deviation 0.01
250mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin plus probenecid1.58 mg/LStandard Deviation 0.87
250mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin plus probenecid0.33 mg/LStandard Deviation 0.16
250mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin plus probenecid2.35 mg/LStandard Deviation 1.15
250mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin alone0.15 mg/LStandard Deviation 0.07
250mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin alone0.85 mg/LStandard Deviation 0.45
250mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin plus probenecid0.49 mg/LStandard Deviation 0.21
500mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin plus probenecid1.18 mg/LStandard Deviation 0.51
500mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin plus probenecid5.18 mg/LStandard Deviation 2.15
500mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin alone0.18 mg/LStandard Deviation 0.14
500mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin alone0.98 mg/LStandard Deviation 0.76
500mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin alone0.85 mg/LStandard Deviation 0.26
500mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin plus probenecid0.49 mg/LStandard Deviation 0.11
500mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin alone0.16 mg/LStandard Deviation 0.05
500mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin plus probenecid2.22 mg/LStandard Deviation 0.56
750mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin plus probenecid6.67 mg/LStandard Deviation 3.09
750mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin plus probenecid1.46 mg/LStandard Deviation 0.78
750mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin alone0.35 mg/LStandard Deviation 0.13
750mg Penicillin Arm 1Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin alone1.97 mg/LStandard Deviation 0.76
750mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin alone0.09 mg/LStandard Deviation 0.03
750mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin plus probenecid3.55 mg/LStandard Deviation 1.45
750mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationUnbound penicillin concentration (mg/L) - penicillin plus probenecid0.81 mg/LStandard Deviation 0.34
750mg Penicillin Arm 2Measurement of Total and Unbound Penicillin-V ConcentrationTotal penicillin concentration (mg/L) - penicillin alone0.45 mg/LStandard Deviation 0.15
Secondary

Measurement of Total and Unbound Probenecid Concentration

Measurement of blood concentration at 45 minutes post observed probenecid dose. Combined data for all participants given that the same dose of probenecid was taken by all participants.

Time frame: 45 minutes post an observed dose.

Population: All 20 participants received the same dose (500mg QDS) of probenecid regardless of study arm. Results are therefore presented for all participants for this outcome.

ArmMeasureValue (MEAN)Dispersion
250mg Penicillin Arm 1Measurement of Total and Unbound Probenecid Concentration79.0 mg/LStandard Deviation 21.4
250mg Penicillin Arm 2Measurement of Total and Unbound Probenecid Concentration6.6 mg/LStandard Deviation 1.5
Secondary

Measurement of Total and Unbound Probenecid Concentration

Measurement of blood concentration at 180 minutes post observed probenecid dose. Combined data for all participants given that the same dose of probenecid was taken by all participants.

Time frame: 180 minutes post an observed dose.

Population: All 20 participants received the same dose (500mg QDS) of probenecid regardless of study arm. Results are therefore presented for all participants for this outcome.

ArmMeasureValue (MEAN)Dispersion
250mg Penicillin Arm 1Measurement of Total and Unbound Probenecid Concentration81.1 mg/LStandard Deviation 20.6
250mg Penicillin Arm 2Measurement of Total and Unbound Probenecid Concentration6.6 mg/LStandard Deviation 1.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026